Back to Search
Start Over
P-195: Lenalidomide, bortezomib, and dexamethasone (RVd) as first-line (1L) therapy in patients who are non-transplanted: results from the Connect® MM registry
- Source :
- Clinical Lymphoma Myeloma and Leukemia. 22:S142
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Cancer Research
Oncology
Hematology
Subjects
Details
- ISSN :
- 21522650
- Volume :
- 22
- Database :
- OpenAIRE
- Journal :
- Clinical Lymphoma Myeloma and Leukemia
- Accession number :
- edsair.doi...........df81cdf697350c207d5bd9ba489c99c9
- Full Text :
- https://doi.org/10.1016/s2152-2650(22)00525-0